@venturebeat.com 3 years ago
Researchers aim to measure the impact of imprecise medical data on AI predictions
@venturebeat.com 5 years ago
HeartFlow’s AI coronary test outperforms conventional alternatives
@venturebeat.com 6 years ago
Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study
@venturebeat.com 6 years ago
Amaranth Medical Provides Clinical and Commercial Update on 115-micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
@venturebeat.com 6 years ago
Svelte Medical Systems Announces Sustained Outstanding Outcomes in Clinical Studies